ARCHIVES

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

ODAC Votes 13:0 to Recommend Perjeta for Accelerated Approval

September 13, 2013

ACS-Roosevelt Awards Go to 19 New Fellows

July 30, 1976

Maryland to Use $1B In Tobacco Funds For Cancer Research, Anti-Smoking Program

June 4, 1999

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

November 4, 1994

Zerhouni Appoints Kington As Deputy Director

February 14, 2003

NCI-Approved Clinical Trials

April 26, 2002